PREVENT AVOIDABLE ERRORS IN ONCOLOGY TRIALS.
Centralizing cardiac safety in early phase oncology trials can help increase patient participation and avoid unwanted errors. Running QTc studies will minimize false readings and include more patients in your trial, saving you time and money.
See how in this infographic. You can view it below, or download it here.
TALK TO ONE OF OUR CARDIAC SAFETY SPECIALISTS
Our team of experts is here to address any of your questions. Submit your contact information and we’ll be in touch to schedule a demo or meeting.